You can view the research column published every month by SMC Laboratories.
2025.01.30
Fibrosis-related factors and pathogenesis of STAM mice
Today, we would like to introduce the correlation between our proprietary STAMTM model and fibrosis-related fa…
READ MORE
2025.01.30
Wnt/β-catenin in STAM: How does it correlate to human liver cancer?
We would like to share with you the HCC-related gene expression data of our proprietary MASH-HCC model (STAMTM…
READ MORE
2025.01.29
Potential MASH biomarker in NASH-HCC model
We would like to introduce the data for a serological marker from our MASH model (STAMTM model). Hepato…
READ MORE
2025.01.29
Fibrosis markers in the STAM model
We would like to introduce a non-invasive fibrosis marker. Currently, the most reliable method for MASH…
READ MORE
2025.01.29
Introduction of DDC-Induced Cholestatic Liver Disease Mouse Model
We would like to introduce mice model of primary sclerosing cholangitis (PSC), as well as 3,5-Diethoxycarbonyl…
READ MORE
2025.01.29
Pre-clinical studies for Cholestatic Liver Diseases: Bile Duct Ligation model
We would like to share with you about our Bile duct ligation (BDL) model, known as a disease model mice for ch…
READ MORE
2025.01.29
Positive control for CCl4 mouse model
We would like to introduce our carbon tetrachloride (CCl4)-induced liver fibrosis model, which is a widely use…
READ MORE
2025.01.29
Proteinuria in the Adriamycin model
When discussing our mouse models of chronic kidney disease (CKD), we are often asked about proteinuria as a ur…
READ MORE
2025.01.29
Drug efficacy evaluation study for fibrotic diseases involving multiple organs
We want to introduce a paper by Insilico Medicine, a company that focuses on fibrosis to develop drugs, and af…
READ MORE
2025.01.29
Introduction of the paper using our UUO model
Today, we would like to introduce a paper published by our client using our Chronic Kidney Disease model. &nbs…
READ MORE
